BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

the first discovery of Kidney cancer Pages on BioPortfolio:

Biotechnology News kidney Search
Renal Data System (USRDS) to issue for the first time a separate report .... People with kidney cancer, regardless of age, seem to benefit from and tolerate
...
http://www.bioportfolio.co.uk/kidney-news.htm...

BioPortfolio - Renal Cancer Kidney Cancer
Kidney Research UK Launches First Ever National Kidney Disease Screening Pilot, WebitPR: Sep 5 2008 12:24AM Matching: renal cancer kidney ...
http://www.bioportfolio.com/indepth/Renal_Cancer_Kidney_Canc...

Biotechnology News kidney sorafenib. eisen. addenbrook. tim. 69 ...
10 Oct 2008 ... People with kidney cancer, regardless of age, seem to benefit from and tolerate sorafenib drug therapy equally well, a new study says. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - Kidney Cancer
Kidney Cancer - BioPortfolio - Indepth. ... BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease ...
http://www.bioportfolio.com/indepth/Kidney_Cancer.html...

Biotechnology News kidney sorafenib. eisen. 843. 835. addenbrook ...
10 Oct 2008 ... Healthcare Medical Life Science Drug Discovery Disease ... 9 (HealthDay News ) -- People with kidney cancer, regardless of age, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - the biotechnology, pharmaceutical, life science and ...
Cancer centre 'could lose 7.5m' Wales Online Oct 11 2008 3:17PM. Limits of rabies vaccine triggering precautions WFMJ 21 - TV Oct 11 2008 3:16PM ...
http://www.bioportfolio.com/...

BioPortfolio's Kidney Cancer News and Headlines
... Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease ... Kidney Cancer News updated every 30 minutes from thousands of internet sites.
...
http://www.bioportfolio.co.uk/Health_News/Kidney_Cancer.shtm...

PREDICTIVE GENETIC TEST FOR BOWEL CANCER TREATMENT IS INTRODUCED ...
17 Mar 2008 ... It is the first time that the European Commission has licensed a bowel ... around the world in the fight against cancer, kidney disease, ...
http://www.bioportfolio.com/biotech_news/Lab21_11.htm...

Biotechnology News kidney Search
Medical Procedure News A study of almost 1500 kidney cancer patients treated at Memorial ... Local Man First Nevadan to Use New Kidney Dialysis Machine ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Biotechnology News kidney pettu. sloan. ketter. impair. forest ...
30 -- Sunitinib (Sutent) is considerably more toxic than interferon-alpha in first-line systemic treatment of metastatic kidney cancer patients, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Results from other life science and pharmaceutical sites:

Kidney International - Kidney cancer in the Swedish Family Cancer ...
Kidney cancer occurs in both sporadic and familial forms. Familial kidney cancer is rare because only a few percent of first-degree relatives share this ...
http://www.nature.com/ki/journal/v61/n5/full/4492947a.html...

Roche - Roche in the first half of 2007: Strong performance continues
Avastin (bevacizumab), the first anti-angiogenic therapy to demonstrate survival benefits in advanced colorectal, breast, lung and kidney cancer, ...
http://www.roche.com/media/media_releases/med-cor-2007-07-19...

The kidney, cancer, and the eye: current concepts. [Surv ...
Multiple cancer syndromes involve both the eye and the kidney. ... tumors can lead to a systemic evaluation and discovery of associated visceral tumors. ...
http://www.ncbi.nlm.nih.gov/pubmed/16263367...

Regression of human kidney cancer following allogeneic stem cell ...
Clear-cell RCC is the dominant histological subtype of kidney cancer, ..... and evolutionary implications of the discovery of HLA class I supermotifs. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=22...

Nature Clinical Practice Urology | Ablative techniques for the ...
Ablative techniques for the management of kidney cancer .... In 1997, Zlotta et al.24 first described the use of RFA to produce extensive, ...
http://www.nature.com/uidfinder/10.1038/ncpuro0802...

Management of kidney cancer: Canadian Kidney Cancer Forum ...
Advanced metastatic kidney cancer (mRCC). Enrolling patients in well-designed clinical trials should always be considered as the first option for patients ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=24...

Anticancer drugs: Autophagy targeted in kidney cancer : Article ...
Research Highlight. Nature Reviews Drug Discovery 7, 731 (September 2008) | doi :10.1038/nrd2674 ... Anticancer drugsAutophagy targeted in kidney cancer ...
http://www.nature.com/nrd/journal/v7/n9/full/nrd2674.html...

Wyeth's TORISEL Receives European Commission Approval for the ...
TORISEL is the only approved cancer therapy that specifically inhibits the mTOR ... TORISEL to the NCCN Kidney Cancer Guidelines as an option in first-line ...
https://www.wyeth.com/news/archive?nav=display&navTo=/wyeth_...

Media releases
9 Sep 2008 ... If approved, RAD001 will become the first oral, once-daily therapy that targets mTOR to treat advanced kidney cancer. ...
http://www.novartis.com/newsroom/media-releases/en/2008/1249...

British Journal of Cancer - Survival from kidney cancer in England ...
23 Sep 2008 ... Survival from kidney cancer in England and Wales up to 2001 ... article will continue into and beyond the first decade of the 21st century. ...
http://www.nature.com/bjc/journal/v99/n1s/full/6604602a.html...

Google Custom Search

Search
  

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo